Takeda

Takeda is talking with European regulators about submitting the data for approval next year.

Novel Cancer Drug Shows Promise Thomas Gryta 2010

Takeda is talking with European regulators about submitting the data for approval next year.

Seattle Genetics, Takeda Lymphoma Drug Shows Success Thomas Gryta 2010

Acclaimed for her design work at Sega for their popular video game RF Online, and most recently the debut issue of X-Men: Fairy Tales, Takeda is looking to make her mark in the U.S. comic field.

C.B. Cebulski Unleashes Martial Arts Horror with “Drain” | Major Spoilers - Comic Book Reviews and News 2009

"We will consider buying back some of our shares in order to mitigate the impact on the stock market and contribute to the smooth disposal of the government-held shares," said JT's Executive Deputy President Munetaka Takeda.

Japan Tobacco's Net Jumps 67% as Tax Bite Fades Hiroyuki Kachi 2012

"We recognize the quake impact was only a one-off, special factor for this fiscal year and the impact was mostly realized in the first quarter," said JT's executive deputy president, Munetaka Takeda .

Quake Disruptions Hit Japan Tobacco Results Hiroyuki Kachi 2011

"We are a blank slate at this moment, and would like to study ways" to proceed with the share buyback plan, should the government continue to hold at least a 33% stake, rather than selling its entire stake, JT's executive deputy president, Munetaka Takeda , said at a press conference.

Japan Tobacco Net Jumps 24% Hiroyuki Kachi 2011

"We are a blank slate at this moment," JT's executive deputy president Munetaka Takeda said at a news conference in late October, describing the company's uncertainty on what to do should the government continue to hold at least a 33% stake.

Japan's Tobacco Farmers Stunt Privatization Plan Hiroyuki Kachi 2011

You are referring to our pharmaceutical company, Takeda, which is developing the new drug that you described.

WHAT HE LEFT BEHIND 2007

Takeda, which is privately held, bought Nycomed for $13.6 billion in a deal that closed Sept. 30.

The Seattle Times 2012

( "Takeda") underscores its position that ACTOS (R) (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.

Presseportal.de 2010